Aarkstore - Herpes Zoster (Shingles) - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Herpes Zoster (Shingles) - Pipeline Review, H2 2014 PowerPoint presentation | free to download - id: 73e009-ZTFjO



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Herpes Zoster (Shingles) - Pipeline Review, H2 2014

Description:

“Herpes Zoster (Shingles) - Pipeline Review, H2 2014”, provides an overview of the Herpes Zoster (Shingles)s therapeutic pipeline. For more details : – PowerPoint PPT presentation

Number of Views:7

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Herpes Zoster (Shingles) - Pipeline Review, H2 2014


1
Aarkstore - Herpes Zoster (Shingles) - Pipeline
Review, H2 2014
www.aarkstore.com
2
Summary
  • Herpes Zoster (Shingles) - Pipeline Review, H2
    2014, provides an overview of the
  • Herpes Zoster (Shingles)s therapeutic pipeline.
  • This Market Research Report provides
    comprehensive information on the therapeutic
  • development for Herpes Zoster (Shingles),
    complete with comparative analysis at various
  • stages, therapeutics assessment by drug target,
    mechanism of action (MoA), route of
  • administration (RoA) and molecule type, along
    with latest updates, and featured news and
  • press releases. It also reviews key players
    involved in the therapeutic development for
    Herpes
  • Zoster (Shingles) and special features on
    late-stage and discontinued projects.

www.aarkstore.com
www.aarkstore.com
3
Scope
  • - The report provides a snapshot of the
    global therapeutic landscape of Herpes Zoster
    (Shingles)- The report reviews key pipeline
    products under drug profile section which
    includes, product description, MoA and RD brief,
    licensing and collaboration details other
    developmental activities - The report reviews
    key players involved in the therapeutics
    development for Herpes Zoster (Shingles) and
    enlists all their major and minor projects- The
    report summarizes all the dormant and
    discontinued pipeline projects - A review of the
    Herpes Zoster (Shingles) products under
    development by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources- Pipeline
    products coverage based on various stages of
    development ranging from pre-registration till
    discovery and undisclosed stages- A detailed
    assessment of monotherapy and combination therapy
    pipeline projects- Coverage of the Herpes Zoster
    (Shingles) pipeline on the basis of target, MoA,
    route of administration and molecule type-
    Latest news and deals relating related to
    pipeline products

www.aarkstore.com
4
Reasons to buy
  • - Provides strategically significant
    competitor information, analysis, and insights to
    formulate effective RD development strategies-
    Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive
    advantage- Develop strategic initiatives by
    understanding the focus areas of leading
    companies- Identify and understand important and
    diverse types of therapeutics under development
    for Herpes Zoster (Shingles)- Plan mergers and
    acquisitions effectively by identifying key
    players of the most promising pipeline- Devise
    corrective measures for pipeline projects by
    understanding Herpes Zoster (Shingles) pipeline
    depth and focus of Indication therapeutics-
    Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and scope- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline

www.aarkstore.com
5
Table of Contents
  • Introduction 6Global Markets Direct
    Report Coverage 6Herpes Zoster (Shingles)
    Overview 7Therapeutics Development 8Pipeline
    Products for Herpes Zoster (Shingles) - Overview
    8Pipeline Products for Herpes Zoster (Shingles)
    - Comparative Analysis 9Herpes Zoster (Shingles)
    - Therapeutics under Development by Companies
    10Herpes Zoster (Shingles) - Pipeline Products
    Glance 12Late Stage Products 12Clinical Stage
    Products 13Early Stage Products 14Unknown Stage
    Products 15Herpes Zoster (Shingles) - Products
    under Development by Companies 16Herpes Zoster
    (Shingles) - Companies Involved in Therapeutics
    Development 17GlaxoSmithKline plc 17

www.aarkstore.com
6
List Of Tables
  • Number of Products under Development for
    Herpes Zoster (Shingles), H2 2014 8Number of
    Products under Development for Herpes Zoster
    (Shingles) - Comparative Analysis, H2 2014
    9Number of Products under Development by
    Companies, H2 2014 11Comparative Analysis by
    Late Stage Development, H2 2014 12Comparative
    Analysis by Clinical Stage Development, H2 2014
    13Comparative Analysis by Early Stage
    Development, H2 2014 14Comparative Analysis by
    Unknown Stage Development, H2 2014 15Products
    under Development by Companies, H2 2014 16Herpes
    Zoster (Shingles) - Pipeline by GlaxoSmithKline
    plc, H2 2014 17Herpes Zoster (Shingles) -
    Pipeline by Merck Co., Inc., H2 2014 18

www.aarkstore.com
7
List Of Figures
  • Number of Products under Development for
    Herpes Zoster (Shingles), H2 2014 8Number of
    Products under Development for Herpes Zoster
    (Shingles) - Comparative Analysis, H2 2014
    9Number of Products under Development by
    Companies, H2 2014 10Comparative Analysis by
    Clinical Stage Development, H2 2014 13Assessment
    by Monotherapy Products, H2 2014 24Number of
    Products by Top 10 Target, H2 2014 25Number of
    Products by Stage and Top 10 Target, H2 2014
    26Number of Products by Top 10 Mechanism of
    Action, H2 2014 27Number of Products by Stage
    and Top 10 Mechanism of Action, H2 2014 28Number
    of Products by Top 10 Route of Administration, H2
    2014 29

www.aarkstore.com
8
Related Market Research reports
  • Corticosteroid-Responsive Dermatoses - Pipeline
    Review, H1 2014
  • Hematological Tumor - Pipeline Review, H1 2014
  • Inflammation - Pipeline Review, H1 2014
  • Opioid Induced Side Effects - Pipeline Review, H1
    2014
  • Skin Infections - Pipeline Review, H1 2014

www.aarkstore.com
9
Related Market Research reports
  • Restenosis - Pipeline Review, H1 2014
  • Tauopathies - Pipeline Review, H1 2014
  • Nasopharyngitis (Common Cold) - Pipeline Review,
    H1 2014
  • Mucopolysaccharidosis III (MPS III) (Sanfilippo
    Syndrome) - Pipeline Review, H1 2014
  • Chemotherapy Induced Peripheral Neuropathy -
    Pipeline Review, H1 2014

www.aarkstore.com
10
Aarkstore - Herpes Zoster (Shingles) - Pipeline
Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us
  • Office
  • Office No. - 809, 8th Floor,
  • B-Wing, Mahaavir Icon, 
  • Plot No.- 89 90, Sector-15,
  • CBD-Belapur, Navi Mumbai 400614, 
  • Maharashtra, India.
  • 24/7 Online Support 91 9987295242
  • General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog http//www.aarkstore.com/blog/
  • Conference http//conference.aarkstore.com/
  • News http//www.aarkstore.com/news

www.aarkstore.com
About PowerShow.com